Selah Technologies,
an advanced materials manufacturer, announced today that the company has received
a $100,000 SBIR Phase I grant from the National Science Foundation (NSF) to
fund continued manufacturing and development activities for the company's Selah
Dots™ nanotechnology. This award is the second NSF SBIR Phase I grant
received by the company.
Selah was recently notified of the award as part of the NSF’s Small
Business
Innovation Research (SBIR) program. “The awarding of this grant is continued
validation of our efforts to develop and deploy Selah Dots™ across a variety
of bioimaging
and bio-sensing applications,” said Dr. Andrew Metters, Chief Technology
Officer for Selah, who will lead the project.
Selah Technologies obtained a worldwide exclusive license in 2006 from Clemson
University to develop and commercialize two nanotechnologies, branded Selah
Dots™ and Selah Tubes™. Selah Dots™ are patent-pending brightly
luminescent
carbon based nanoparticles for use primarily as imaging agents for the biomedical
industry with supplementary applications including solar cells and anticounterfeiting,
among others. Selah Tubes™, enriched carbon nanotubes protected
under US Patent No. 7,374,685, have a number of applications due to their
impressive electrical and thermal conductivity properties.
Posted December 3rd, 2008
